Catalyst Biosciences Announces The Pricing Of Public Offering Of Common Stock
February 13, 2018 at 12:50 PM EST
Catalyst Biosciences, Inc. today announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock, offered at a price of $34.00 per share to the public.
